chr17-39665182-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003673.4(TCAP):​c.-178G>T variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.614 in 629,156 control chromosomes in the GnomAD database, including 125,022 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 23698 hom., cov: 33)
Exomes 𝑓: 0.64 ( 101324 hom. )

Consequence

TCAP
NM_003673.4 upstream_gene

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0460

Publications

37 publications found
Variant links:
Genes affected
TCAP (HGNC:11610): (titin-cap) Sarcomere assembly is regulated by the muscle protein titin. Titin is a giant elastic protein with kinase activity that extends half the length of a sarcomere. It serves as a scaffold to which myofibrils and other muscle related proteins are attached. This gene encodes a protein found in striated and cardiac muscle that binds to the titin Z1-Z2 domains and is a substrate of titin kinase, interactions thought to be critical to sarcomere assembly. Mutations in this gene are associated with limb-girdle muscular dystrophy type 2G. [provided by RefSeq, Jul 2008]
TCAP Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 25
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal recessive limb-girdle muscular dystrophy type 2G
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-39665182-G-T is Benign according to our data. Variant chr17-39665182-G-T is described in ClinVar as Benign. ClinVar VariationId is 672043.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.684 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003673.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TCAP
NM_003673.4
MANE Select
c.-178G>T
upstream_gene
N/ANP_003664.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TCAP
ENST00000309889.3
TSL:1 MANE Select
c.-178G>T
upstream_gene
N/AENSP00000312624.2
TCAP
ENST00000578283.1
TSL:5
c.-178G>T
upstream_gene
N/AENSP00000462787.1

Frequencies

GnomAD3 genomes
AF:
0.523
AC:
79415
AN:
151982
Hom.:
23693
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.227
Gnomad AMI
AF:
0.740
Gnomad AMR
AF:
0.536
Gnomad ASJ
AF:
0.683
Gnomad EAS
AF:
0.410
Gnomad SAS
AF:
0.703
Gnomad FIN
AF:
0.691
Gnomad MID
AF:
0.630
Gnomad NFE
AF:
0.656
Gnomad OTH
AF:
0.554
GnomAD4 exome
AF:
0.643
AC:
306672
AN:
477056
Hom.:
101324
Cov.:
5
AF XY:
0.651
AC XY:
164713
AN XY:
252952
show subpopulations
African (AFR)
AF:
0.231
AC:
3223
AN:
13952
American (AMR)
AF:
0.575
AC:
16373
AN:
28476
Ashkenazi Jewish (ASJ)
AF:
0.686
AC:
10505
AN:
15310
East Asian (EAS)
AF:
0.466
AC:
13986
AN:
29998
South Asian (SAS)
AF:
0.740
AC:
38449
AN:
51946
European-Finnish (FIN)
AF:
0.682
AC:
19589
AN:
28720
Middle Eastern (MID)
AF:
0.709
AC:
1631
AN:
2300
European-Non Finnish (NFE)
AF:
0.666
AC:
186249
AN:
279572
Other (OTH)
AF:
0.622
AC:
16667
AN:
26782
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
5350
10700
16050
21400
26750
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
964
1928
2892
3856
4820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.522
AC:
79433
AN:
152100
Hom.:
23698
Cov.:
33
AF XY:
0.524
AC XY:
38927
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.226
AC:
9388
AN:
41502
American (AMR)
AF:
0.537
AC:
8210
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.683
AC:
2370
AN:
3472
East Asian (EAS)
AF:
0.410
AC:
2113
AN:
5154
South Asian (SAS)
AF:
0.704
AC:
3404
AN:
4834
European-Finnish (FIN)
AF:
0.691
AC:
7320
AN:
10588
Middle Eastern (MID)
AF:
0.616
AC:
181
AN:
294
European-Non Finnish (NFE)
AF:
0.656
AC:
44604
AN:
67948
Other (OTH)
AF:
0.555
AC:
1171
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1684
3368
5052
6736
8420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
690
1380
2070
2760
3450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.625
Hom.:
48645
Bravo
AF:
0.496
Asia WGS
AF:
0.579
AC:
2015
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.2
DANN
Benign
0.82
PhyloP100
0.046
PromoterAI
-0.024
Neutral
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs931992; hg19: chr17-37821435; API